The week in health tech, explained in plain English.Get the free newsletter →
September 20, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Finance

Hospital Margins Lag as Expenses Outpace Inflation

Hospital finances remain squeezed. Operating margins grew slightly month over month in April but stayed well behind 2025 levels, according to Kaufman Hall's National Hospital Flash Report, released June 18 and based on data from more than 1,300 hospitals collected by Strata Decision Technology.

The report reflects a now-familiar tension: revenue and patient volumes are trending upward, but expenses are climbing faster than inflation. Labor, drug, and supply costs continue to pressure the bottom line, offsetting the benefit of higher demand. The result is margins that look healthier than the worst of the pandemic years yet remain too thin to give most systems comfortable financial footing.

For hospital operators, the message is that volume recovery alone will not fix the math. As long as cost growth runs ahead of reimbursement and inflation, margin improvement will stay incremental. Expect continued focus on labor efficiency, supply chain costs, and pricing as systems try to close the gap.

More in Finance

Finance

FDA Approves First Sanfilippo Gene Therapy From Ultragenyx

The FDA approved Ultragenyx's Fayuvi as the first therapy targeting the underlying cause of Sanfilippo syndrome type A.

Why it matters: It gives children with an ultra-rare, fatal neurological disorder their first approved treatment aimed at the disease's root cause.

Finance

Definium's LSD Therapy Eases Anxiety in Second Large Trial

Definium said its LSD-based therapy reduced anxiety in a second large trial, advancing the psychedelic drug class toward regulatory approval.

Why it matters: Positive late-stage data pushes psychedelic medicine closer to its first approvals, signaling a potential new category of fast-acting mental-health treatments.

Finance

Revenue Cycle Leadership Reshaped by AI at Nebraska Medicine

Nebraska Medicine's Sheila Augustine describes how AI is turning revenue cycle leadership into a strategic role focused on people, technology, and clinical partnership.

Why it matters: Revenue cycle drives hospital financial health, and AI is redefining the skills leaders need to protect it.